You have 9 free searches left this month | for more free features.

bendamustine

Showing 1 - 25 of 148

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Follicular Lymphoma Trial (Bendamustine, Rituximab, Tazemetostat)

Not yet recruiting
  • Follicular Lymphoma
  • Bendamustine
  • +2 more
  • (no location specified)
Sep 20, 2022

Mantle Cell Lymphoma, Non-hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in Madison (Bendamustine, Obinutuzumab)

Recruiting
  • Mantle Cell Lymphoma
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Mar 7, 2022

Relapsed T-Cell Lymphoma, Refractory T-Cell Lymphoma, Non Hodgkin Lymphoma Trial in Winston-Salem (CPI 613, Bendamustine)

Recruiting
  • Relapsed T-Cell Lymphoma
  • +2 more
  • CPI 613
  • Bendamustine
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Aug 27, 2021

Chronic Lymphocytic Leucemia Trial in Cologne (Bendamustine, GA101, CAL-101)

Active, not recruiting
  • Chronic Lymphocytic Leucemia
  • Bendamustine
  • +2 more
  • Cologne, Germany
    German CLL Study Group
Apr 29, 2022

Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Classical Hodgkin Lymphoma Trial in Atlanta (Bendamustine, Gemcitabine,

Active, not recruiting
  • Recurrent Hodgkin Lymphoma
  • +3 more
  • Bendamustine
  • +2 more
  • Atlanta, Georgia
  • +1 more
Aug 25, 2021

Mantle Cell Lymphoma Trial in Saint Louis (Bendamustine, Rituximab, Acalabrutinib)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Bendamustine
  • +7 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Feb 2, 2022

Multiple Myeloma Trial in Berne (Melphalan, Bendamustine)

Completed
  • Multiple Myeloma
  • Berne, Switzerland
    Department for Medical Oncology University Hospital/Inselspital
Jul 29, 2021

Mantle Cell Lymphoma Trial (parsaclisib, rituximab, bendamustine)

Withdrawn
  • Mantle Cell Lymphoma
  • (no location specified)
Apr 22, 2022

Relapsed, Refractory, Multiple Myeloma Trial in Guangzhou (Pomalidomide, Bendamustine, Dexamethasone)

Not yet recruiting
  • Relapsed, Refractory, Multiple Myeloma
  • Guangzhou, Please Select, China
    Sun Yat-sen University Cancer Center
Feb 17, 2021

Leukemia, Lymphocytic, Chronic, B-Cell Trial in Austria (Bendamustine, Alemtuzumab)

Completed
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Innsbruck, Tirol, Austria
  • +6 more
Feb 15, 2022

Indolent Non-hodgkin Lymphoma Trial in München (Obinutuzumab, Bendamustine)

Active, not recruiting
  • Indolent Non-hodgkin Lymphoma
  • München, Bavaria, Germany
    Klinikum der Universität München
Jul 23, 2021

Waldenstrom Macroglobulinemia Trial in Canada (Acalabrutinib, Bendamustine, Rituximab)

Recruiting
  • Waldenstrom Macroglobulinemia
  • Vancouver, British Columbia, Canada
  • +3 more
Jul 23, 2021

Chronic Lymphocytic Leucemia Trial in Cologne (Bendamustine, GA101, ABT-199)

Active, not recruiting
  • Chronic Lymphocytic Leucemia
  • Bendamustine
  • +2 more
  • Cologne, Germany
    German CLL Study Group
Aug 23, 2021

Mantle Cell Lymphoma Trial in Boston (Rituximab, Bendamustine, Cytarabine)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Boston, Massachusetts
  • +2 more
Jun 9, 2021

Indolent Non-Hodgkin's Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma Trial in United States (Duvelisib, Placebo,

Withdrawn
  • Indolent Non-Hodgkin's Lymphoma
  • +3 more
  • Plainville, Connecticut
  • +6 more
Mar 15, 2021

Lymphoma, Follicular Trial in United States (Bendamustine, Rituximab, Y-90 ibritumomab)

Completed
  • Lymphoma, Follicular
  • Bendamustine
  • +2 more
  • Scarborough, Maine
  • +3 more
Apr 27, 2021

Lymphoma, Non-Hodgkin, Lymphoma Trial in Davis, San Diego, San Francisco (Carfilzomib, Bendamustine, Rituximab)

Completed
  • Lymphoma, Non-Hodgkin
  • Lymphoma
  • Davis, California
  • +2 more
Apr 21, 2021

Lymphatic Diseases Trial in Italy (Brentuximab Vedotin, Bendamustine)

Terminated
  • Lymphatic Diseases
  • Brentuximab Vedotin
  • Bendamustine
  • Bologna, BO, Italy
  • +4 more
May 26, 2021

Multiple Myeloma, Chronic Kidney Disease Trial in United Kingdom (Bortezomib, Thalidomide, Bendamustine)

Completed
  • Multiple Myeloma
  • Chronic Kidney Disease
  • Basingstoke, United Kingdom
  • +8 more
Jan 26, 2022

Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)

Active, not recruiting
  • Multiple Myeloma
  • +4 more
  • Total Body Irradiation
  • +5 more
  • Los Angeles, California
    Cedars Sinai Medical Center
Jul 15, 2022

Non-Hodgkin's Lymphoma Trial in Philadelphia (drug, procedure, genetic)

Active, not recruiting
  • Non-Hodgkin's Lymphoma
  • Bendamustine
  • +6 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jun 3, 2021

Non-Hodgkin's Lymphoma Trial in United States (ABT-199, Rituximab, Bendamustine)

Completed
  • Non-Hodgkin's Lymphoma
  • La Jolla, California
  • +7 more
Jul 29, 2021

Bendamustine, Multiple Myeloma Trial in Shenyang (Bendamustine)

Recruiting
  • Bendamustine
  • Multiple Myeloma
  • Bendamustine
  • Shenyang, Liaoning, China
    Shengjing Hospital of China Medical University
Aug 7, 2021

Lymphoma, Non-Hodgkin Trial in Canada, United States (TAK-659, Bendamustine, Rituximab)

Terminated
  • Lymphoma, Non-Hodgkin
  • Tucson, Arizona
  • +12 more
Dec 7, 2021

Leukemia, Acute Lymphoblastic, Acute Myeloid Leukemia, Mixed-Lineage Acute Leukemias Trial in Saint-Petersburg (Allogeneic stem

Completed
  • Leukemia, Acute Lymphoblastic
  • +2 more
  • Allogeneic stem cell transplantation
  • +3 more
  • Saint-Petersburg, Russian Federation
    First Pavlov State Medical University of St. Petersburg
Nov 19, 2020